FindTrial
Sign In

Diffuse laser treatment for prophylaxis of the fellow eye with age-related maculopathy in patients with exudative age-related macular degeneration (AMD)

Diffuse laser treatment for prophylaxis of the fellow eye with age-related maculopathy in patients with exudative age-related macular degeneration (AMD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74548520
Enrollment
Unknown
Registered
2006-09-29
Start date
2005-07-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases: Age-related macular degeneration (AMD) Eye Diseases Other retinal disorders

Interventions

Age-related macular degeneration (AMD) is one of the leading causes of blindness in the western world. Currently there is no cure for this disease and treatment options for stabilising the vision are

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Outpatients aged 55 or over with a diagnosis of exudative age-related macular degeneration in one eye and early changes of AMD (drusen and retinal pigment changes) in the other eye

Exclusion criteria

Exclusion criteria: 1. Patients in whom colour fundus photography is not possible due to ocular media opacities or other disabilities 2. Those with other retinal diseases.

Design outcomes

Primary

MeasureTime frame
Rate of development of CNV—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026